Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

NCT04218162 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

294

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Migraine

Interventions

DRUG: Lasmiditan 50mg
DRUG: Lasmiditan 100mg
DRUG: Placebo

Sponsor

IlDong Pharmaceutical Co Ltd